AKT1 and nervous system disorder: Previous studies have reported that both VPA and ALA exert neuroprotective effects in various neurological disease models through activation of the PI3K/AKT pathway, thereby attenuating apoptosis and inflammation (Fahmy et al., 2024; Gurpur et al., 2009; Li and Sui, 2020).